Put Options

13 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$10.71 - $17.11 $1.28 Million - $2.04 Million
-119,200 Reduced 92.26%
10,000 $126,000
Q2 2024

Aug 14, 2024

SELL
$3.89 - $20.97 $1.71 Million - $9.23 Million
-440,100 Reduced 77.31%
129,200 $1.64 Million
Q1 2024

May 15, 2024

BUY
$3.76 - $6.02 $498,576 - $798,252
132,600 Added 30.36%
569,300 $2.72 Million
Q4 2023

Feb 14, 2024

SELL
$4.8 - $7.67 $2.57 Million - $4.1 Million
-534,700 Reduced 55.04%
436,700 $2.1 Million
Q2 2023

Aug 14, 2023

SELL
$6.67 - $9.52 $42,688 - $60,928
-6,400 Reduced 0.65%
971,400 $7.22 Million
Q1 2023

May 12, 2023

SELL
$5.76 - $12.48 $1.58 Million - $3.43 Million
-274,600 Reduced 21.93%
977,800 $6.78 Million
Q4 2022

Feb 10, 2023

BUY
$8.86 - $25.04 $3.94 Million - $11.1 Million
444,800 Added 55.08%
1,252,400 $12.9 Million
Q3 2022

Nov 14, 2022

SELL
$18.2 - $76.12 $1.33 Million - $5.56 Million
-73,000 Reduced 8.29%
807,600 $14.7 Million
Q2 2022

Aug 12, 2022

BUY
$36.28 - $75.29 $9.04 Million - $18.8 Million
249,100 Added 39.45%
880,600 $45.3 Million
Q1 2022

May 16, 2022

BUY
$69.73 - $142.9 $30.1 Million - $61.7 Million
431,900 Added 216.38%
631,500 $46.5 Million
Q4 2021

Feb 08, 2022

BUY
$134.56 - $217.97 $25.8 Million - $41.7 Million
191,500 Added 2364.2%
199,600 $28.6 Million
Q3 2021

Nov 15, 2021

SELL
$177.8 - $270.58 $7.54 Million - $11.5 Million
-42,400 Reduced 83.96%
8,100 $1.68 Million
Q2 2021

Sep 13, 2021

BUY
$121.0 - $257.67 $6.11 Million - $13 Million
50,500 New
50,500 $10.7 Million

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $729M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.